Kotyark Industries Secures ₹173.45 Crore Biodiesel Allocation from OMCs
Kotyark Industries Limited secured a ₹173.45 Crore biodiesel allocation from IOCL, BPCL, and HPCL. The allocation is for supplies in Gujarat during June-August 2026, with a 92-day execution period from the contract award. This strengthens Kotyark's position in the OMC biodiesel supply ecosystem.
The contract value is substantial and directly contributes to the company's revenue, indicating a medium-term impact on its financial performance and market presence.
The company has secured a significant contract, which is a positive development for its business and strengthens its market position.
Kotyark Industries Limited has announced receiving a total biodiesel allocation of ₹173.45 Crore from Indian Oil Corporation Limited (IOCL), Bharat Petroleum Corporation Limited (BPCL), and Hindustan Petroleum Corporation Limited (HPCL). This allocation is pursuant to an OMC tender and is for supplies in Gujarat during the period of June to August 2026.
The execution period for the contract is 92 days from the Award of Contract, subject to requisite Indents/Supply Orders and applicable terms and conditions. The Chairman & Managing Director, Mr. Gaurang Rameshchandra Shah, stated that this significant milestone strengthens Kotyark's participation in the OMC biodiesel supply ecosystem and reflects growing engagement with major Oil Marketing Companies.
He further added that the allocation provides an opportunity to demonstrate the company's manufacturing capabilities, execution discipline, and commitment to reliable supply, aligning with India's transition towards cleaner fuels and the increasing focus on biofuels. Kotyark is well-positioned to cater to the requirements of OMCs, bulk buyers, and industrial customers with its expanded manufacturing capacity and flexible multi-feedstock platform. The company remains focused on disciplined execution, strengthening customer relationships, and enhancing manufacturing platform utilization for sustainable growth.
What to do with a filing like this
Kotyark Industries Limited filed this with the NSE as a statutory disclosure, categorised under new orders. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kotyark Industries Limited. Read the original for the full detail.